1,3-Dimethyl-4-nitro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

trans-Crotononitrile (contains ca. 20% cis- isomer)>75.0%(GC)25mL

3-Furylboronic Acid (contains varying amounts of Anhydride)5g

2-(1-Methoxycyclopropyl)acetic acid, 95%, 1g

2-(1-Oxo-1,3-dihydro-isoindol-2-yl)-2-phenyl-N-thiazol-2-yl-acetamide, 95%, 250mg

S-Trityl-L-cysteine, 97%, 100g

2,7-dimethyl[1,3]thiazolo[4,5-d]pyridazin-4(5H)-one, 95.0%, 250mg

1-(cyclohexylmethyl)piperidine-3-carboxylic acid hydrochloride, 250mg

4,4,5,5-Tetramethyl-2-(4-((trifluoromethyl)thio)phenyl)-1,3,2-dioxaborolane, 95.0%, 5g

Di-2-pyridyl Carbonate>98.0%(T)1g

Ethyl 5-chlorothiazolo[5,4-b]pyridine-2-carboxylate, 95.0%, 5g

D-Sorbitol, min. 98%, for biochemistry, 1 kg, plastic packaging.

Naphtho[1,2-c:5,6-c']bis([1,2,5]oxadiazole)>95.0%(HPLC)200mg